Fuld

NOVEMBER 1, 2022

In this role, Brad will advise our teams and clients from the Health and Life Sciences industries, and promote our portfolio of solutions, including market and business research, competitive intelligence, thought leadership, data analytics, strategic insights, and shared services.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Alpha Sense BI

AUGUST 30, 2023

Artificial intelligence (AI) in asset management has steadily grown over the past several years as even formerly slow adopters are seeing the value and necessity in using it. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market.

Management 98

Management Biotech Due Diligence Algorithm 98

ArchIntel

JUNE 9, 2021

It will be up to each telco’s competitive intelligence professional to deliver the insights needed to capture market share. Executive Profile: Kevin Cooke, Business Intelligence Manager at Verizon Wireless. Kevin Cooke is a business intelligence manager at Verizon Wireless, working out of Hopewell, New Jersey.

Competitive 104

Competitive Competitive Intelligence Biotech Briefing 104

IT Business Edge

JULY 12, 2022

In January, the company announced $9 billion in new capital for venture opportunities, growth stage and biotech. Read next: Top Artificial Intelligence (AI) Software 2022. Andreessen Horowitz certainly has lots of fire power for many more deals. Lightspeed. Lightspeed got its start at the depths of the dotcom bust – October 2000.

Startups 101

Startups Capital Biotech Finance 101

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

BIS Research

MARCH 19, 2019

According to the recent market intelligence report published by BIS Research, titled Global Precision Medicine Market – Analysis and Forecast (2018 – 2028) , the precision medicine market was estimated at $78.85 billion in 2018 and is expected to reach $216.75 billion by 2028.

Globalization 64

Globalization Biotech Marketing Marketing 64

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

APRIL 29, 2024

The Transformative Effect of Generative AI By 2025, it is estimated that more than 75% of venture capital (VC) and early-stage investor executive reviews will be informed using artificial intelligence (AI) and data analytics. There is no doubt that generative AI has emerged as a powerful tool in the investment space.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

JANUARY 26, 2024

This year, the Conference covered developments ranging from digital health and the integration of artificial intelligence (AI) to deep learning, gene editing, bioengineering, implantable technology, medical funding, personalized care, service automation, and much more. Sign up for your free trial today. The post Key Takeaways from J.P.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. That’s why more professionals are turning to market intelligence solutions like AlphaSense.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

APRIL 19, 2024

Artificial intelligence is being used to unlock unprecedented workflows like remote monitoring, servicing, and equipment operation—increasing efficiency while saving countless resources. That’s why you need a tool that does all the heavy lifting for you, so you can focus on leveraging and analyzing information rather than searching for it.

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Alpha Sense BI

APRIL 12, 2024

AlphaSense, a leading artificial intelligence (AI)-based market intelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. With a doctor, I’m more interested in what treatments are you using.

Primary Research 52

Primary Research Advantage Advantage Research 52

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He holds B.A. degrees in Neuroscience and Behavior, Genetics, and Economics from Columbia University.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

NOVEMBER 9, 2022

The lowered guidance reflects softer results for Intelligence & Space and Missiles & Defense. M&A IPOs to watch in Pharma and Biotech. RTX lowered its full-year revenue outlook to $67 billion – $67.3 billion from $67.75 billion – $68.75 Zaslav, President, CEO & Director. JOYY Inc. [YY]. Scroll back to top.

Sales 52

Sales Loss Capital Biotech 52

Alpha Sense BI

MARCH 4, 2024

Increasingly, artificial intelligence (AI) is transforming the delivery and speed of pharmaceutical drugs to the market. AI is solving challenges that come with traditional clinical processes, prompting a surge in AI-based initiatives aimed at reducing costs and expediting development timelines.

Biotech 52

Biotech Pharmaceutical Intelligence Intelligence 52

Alpha Sense BI

MARCH 13, 2024

Related Reading: How Artificial Intelligence is Reshaping Drug Development Race to Bring GLP-1 Assets to Market According to the Journal of the American Medical Association (JAMA), glucagon-like peptide 1 (GLP-1) agonists are medications approved for the treatment of diabetes that have also recently gained popularity for off-label weight loss.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach. The Value: AlphaSense is an AI-powered search engine for market intelligence.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Happy Market

MAY 9, 2022

Founded in 2007, Civic Science is a consumer intelligence research platform that polls millions of Americans each week covering thousands of topics. Founded in 2007, Civic Science is a consumer intelligence research platform that polls millions of Americans each week covering thousands of topics.

Management 52

Management Entertainment Market Research Marketing Research 52